Generation Bio EBITDA 2020-2023 | GBIO
Generation Bio ebitda from 2020 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Generation Bio Annual EBITDA
(Millions of US $) |
| 2023 |
$-133 |
| 2022 |
$-136 |
| 2021 |
$-115 |
| 2020 |
$-78 |
| 2019 |
$-60 |
Generation Bio Quarterly EBITDA
(Millions of US $) |
| 2023-12-31 |
$-37 |
| 2023-09-30 |
$-30 |
| 2023-06-30 |
$-33 |
| 2023-03-31 |
$-34 |
| 2022-12-31 |
$-33 |
| 2022-09-30 |
$-31 |
| 2022-06-30 |
$-37 |
| 2022-03-31 |
$-34 |
| 2021-12-31 |
$-30 |
| 2021-09-30 |
$-30 |
| 2021-06-30 |
$-30 |
| 2021-03-31 |
$-25 |
| 2020-12-31 |
$-23 |
| 2020-09-30 |
$-20 |
| 2020-06-30 |
$-17 |
| 2020-03-31 |
$-17 |
| 2019-12-31 |
|
| 2019-09-30 |
$-16 |
| 2019-06-30 |
$-15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
